Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SCY | Ann: Smiths City Group Limited ("SCY") - Delisting | 02/02/23 | 0 | 254 | |||
|
|||||||
SCY | Ann: EX SCGL LIMITED (FORMERLY SMITHS CITY GROUP LIMITED) (IN RE | 01/02/23 | 0 | 138 | |||
|
|||||||
SCY | Ann: RA: SCY: Smiths City enters receivership at Board's invitation | 22/05/20 | 0 | 368 | |||
|
|||||||
SCY | Ann: MKTUPDTE: SCY: Smiths City - Store Closures | 22/05/20 | 0 | 444 | |||
|
|||||||
SCY | Ann: TRANSACT: SCY: Conditions Update | 21/05/20 | 0 | 371 | |||
|
|||||||
SCY | Ann: TRANSACT: SCY: Smiths City Conditional Sale - Clarification | 20/05/20 | 0 | 357 | |||
|
|||||||
SCY | Ann: Smiths City Group Limited (“SCY”) – Suspension of quotation | 18/05/20 | 0 | 330 | |||
|
|||||||
SCY | Ann: Sale of Smiths City Business | 18/05/20 | 0 | 351 | |||
|
See All Discussions